Detection of visual field progression in glaucoma

Klinische Monatsblatter fur Augenheilkunde

Volumn 225, Issue 5, 2008, Pages 342-345

  Kovalska, M ^a   Grieshaber, Matthias C ^a   Schotzau A ^a   Katamay, R ^a   Hauenstein, D ^a   Flammer, J ^a   Orgul S ^a  

^a UNIVERSITY EYE CLINIC   (Switzerland)

Author keywords

Glaucoma; Progressive damage; Visual field

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PERIMETRY; TREND STUDY; VISUAL FIELD; VISUAL FIELD DEFECT;

AGED; ALGORITHMS; DIAGNOSIS, COMPUTER-ASSISTED; DISEASE PROGRESSION; GLAUCOMA; HUMANS; MIDDLE AGED; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; VISUAL FIELDS;

EID: 47649124485     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1027289     Document Type: Article

References (25)

1. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998; 126: 498-505
2. Anderson DR. Collaborative normal tension glaucoma study. Curr Opin Ophthalmol 2003; 14: 86-90
3. Caprioli J. Automated perimetry in glaucoma. Am J Ophthalmol 1991; 111: 235-239
4. Chauhan BC, Tompkins JD, LeBlanc RP et al. Characteristics of frequency-of-seeing curves in normal subjects, patients with suspected glaucoma, and patients with glaucoma. Invest Ophthalmol Vis Sci 1993; 34: 3534-3540
5. Crabb DP, Edgar DF, Fitzke FW et al. New approach to estimating variability in visual field data using an image processing technique. Br J Ophthalmol 1995; 79: 213-217
6. Feiner L, Piltz-Seymour JR. Collaborative Initial Glaucoma Treatment Study: a summary of results to date. Curr Opin Ophthalmol 2003; 14: 106-111
7. Fitzke FW, McNaught AI. The diagnosis of visual field progression in glaucoma. Curr Opin Ophthalmol 1994; 5: 110-115
8. Flammer J, Eppler E, Niesel P. Die quantitative Perimetrie beim Glaukompatienten ohne lokale Gesichtsfelddefekte. Graefe's Arch Clin Exp Ophthalmol 1982; 219: 92-94
9. Gandolfi SA. Improvement of visual field indices after surgical reduction of intraocular pressure. Ophthalmic Surg 1995; 26: 121-126
10. Gordon MO, Beiser JA, Brandt JD et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120: 714-720
11. Heijl A, Leske MC, Bengtsson B et al. Measuring visual field progression in the Early Manifest Glaucoma Trial. Acta Ophthalmol Scand 2003; 81: 286-293
12. Heijl A, Leske MC, Bengtsson B et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002; 120: 1268-1279
13. Heijl A, Lindgren A, Lindgren G. Test-retest variability in glaucomatous visual fields. Am J Ophthalmol 1989; 108: 130-135
14. Heijl A, Lindgren G, Olsson J. Normal variability of static perimetric threshold values across the central visual field. Arch Ophthalmol 1987; 105: 1544-1549
15. Heijl A, Lindgren G, Olsson J et al. Visual field interpretation with empiric probability maps. Arch Ophthalmol 1989; 107: 204-208
16. Kass MA, Heuer DK, Higginbotham EJ et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120: 701-713
17. Leske MC, Heijl A, Hussein M et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003; 121: 48-56
18. Lichter PR, Musch DC, Gillespie BW et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001; 108: 1943-1953
19. Nouri-Mahdavi K, Hoffman D, Ralli M et al. Comparison of methods to predict visual field progression in glaucoma. Arch Ophthalmol 2007; 125: 1176-1181
20. Quigley HA, Addicks EM, Green WR. Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol 1982; 100: 135-146
21. Schulzer M. Errors in the diagnosis of visual field progression in normal-tension glaucoma. Ophthalmology 1994; 101: 1589-1594
22. Spry PG, Johnson CA. Identification of progressive glaucomatous visual field loss. Surv Ophthalmol 2002; 47: 158-173
23. The AGIS Investigators. The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000; 130: 429-440
24. Vesti E, Johnson CA, Chauhan BC. Comparison of different methods for detecting glaucomatous visual field progression. Invest Ophthalmol Vis Sci 2003; 44: 3873-3879
25. Wilkins MR, Fitzke FW, Khaw PT. Pointwise linear progression criteria and the detection of visual field change in a glaucoma trial. Eye 2006; 20: 98-106